Impax Laboratories (IPXL) Has More Upside, Piper Jaffray Says; PT Raised
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Goldman Sachs Lists Healthcare Co. That May Benefit From Tax Inversion (MYL) (IPXL) (AKRX) (SLXP) (SYK)
June 30, 2014 10:03 AM EDTIn a research note Monday, analyst Jami Rubin of Goldman Sachs listed names of companies that could potentially benefit from a tax inversion. The topic is timely considering recent M&A in the healthcare space.
"Interest in tax inversions is intensifying across healthcare driven by the desire to achieve a more competitive tax structure. While we dont expect tax law changes near-term, concern is rising with more deals. Moreover, investors continue to reward companies looking to unlock value through greater tax efficiency a key... More
